论文信息 - The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells - 字舞流文

The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells

U. Steidl | U. Rohr | J. Neukirchen | R. Fenk | R. Haas | R. Kronenwett | U. Steidl | A. Rohrbeck | A. Meier | G. Garcia-Pardillos